VivoSeq
Other

Prediabetes

1

Pipeline Programs

16

Active Trials

5

Companies Involved

PreDiabetes is an early-stage landscape with 1 program across 5 companies. The most active players are Eli Lilly, Astellas, Novartis.

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

34/100

Mech. Concentration

100/100

Completion Rate

96/100

Attrition Rate

2/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs

Trial Status

43

clinical trials

Completed23 · 53%
Not yet recruiting8 · 19%
Recruiting8 · 19%
Unknown status3 · 7%
Withdrawn1 · 2%

Trial Activity

43 trials

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
Recruiting·MMayo Clinic·Phase 2·NCT06967558·60 enrolled
Mechanisms for Activation of Beige Adipose Tissue in Humans
Recruiting··Phase 2·NCT04666636·65 enrolled
Reversal to Normoglycemia by Treating Prediabetes
Not yet recruiting··Phase 3·NCT07392151·158 enrolled
Henagliflozin's Impact on Prediabetes Remission
Not yet recruiting·SShandong Provincial Hospital·Phase 4·NCT06448130·984 enrolled
Pilot Trial of a Risk-informed Shared-decision Engagement Strategy
Not yet recruiting·JJohns Hopkins University·Preclinical·NCT07553325·120 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)